References
- Rubinfeld B, Souza B, Albert I, et al. Association of the APC gene product with fi-catenin. Science 1993; 262: 1743–5.
- Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999; 24: 73–6.
- Sieber OM, Tomlison IP, Lamlum H. The adenomatous polyposis coli (APC) tumour suppressor—genetics, function and disease. Mol Med Today 2000; 6: 462–9.
- Peifer M, Polakis P. Wnt signaling in oncogenesis and embriogenesis—a look outside the nucleus. Science 2000; 287: 1606–9.
- Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159–70.
- Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589–600.
- Smith KJ, Johnson KA, Bryan TM, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993; 90: 2846–50.
- Guilford P. E-cadherin downregulation in cancer: fuel on the fire?Mol Med Today 1999; 5: 172–7.
- Berx G, Staes K, van Hengel J, et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995; 26: 281–9.
- Efstathiou JA, Liu D, Wheeler JMD, et al. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. PNAS Online 1999; 96: 2316–21.
- Berx G, Becker KF, Hofler H, et al. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998; 12: 226–37.
- Machado JC, Soares P, Carneiro F, et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 1999; 79: 459–65.
- Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402–5.
- Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994; 54: 2852–5.
- Velickovic M, Delahunt B, Stfirkel S, et al. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Cancer Res 2001; 61: 4815–9.
- Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor sup-pressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 2001; 98: 7504–9.
- DalCin P, Li FP, Prout GR Jr, et al. Involvement of chromosomes 3 and 5 in renal cell carcinoma. Cancer Genet Cytogenet 1988; 35: 41–6.
- Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg Classification of renal cell tumours. J Pathol 1997; 183: 131–3.
- Ogawa 0, Habuch T, Kakehi Y, et al. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Cancer Res 1992; 52: 1881–5.
- Störkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma. Cancer 1997; 80: 987–9.
- Peéina-Slaus N, Pavelié K, Pavelié J. Loss of heterozygosity and protein expression of APC gene in renal cell carcinomas. J Mol Med 1999; 77: 446–53.
- Kraus C, Ballhausen WG. Two intragenic polymorphisms of the APC-gene detected by PCR and enzymatic digestion. Hum Genet 1992; 88: 705–6.
- Gao X, Zacharek A, Grignon D, et al. High frequency of loss of expression and allelic deletion of the APC and MCC genes in human prostate cancer. Int J Oncol 1995; 6: 111–17.
- Peéina-Slaus N, Gall-Trogelj K, Kapitanovié S, Pavelié J, Pavelié K. Novel alleles of the D16S752 polymorphic genetic marker linked to E-cadherin gene: a potential population marker. Coll Antropol 2002; 26: 85–8.
- Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345–7.
- Ionov Y, Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558–61.
- Huiping C, Sigurgeirsdottir JR, Jonasson JG, et al. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer 1999; 81: 1103–10.
- Tycko B. Epigenetic gene silencing in cancer. J Clin Invest 2000; 105: 401–7.
- Sakamoto Y, Kitazawa R, Maeda S, et al. Methylation of CpG loci in 5-flanking region alters steady-state expression of adenomatous polyposis coli gene in colon cancer cell lines. J Cell Biochem 2001; 80: 415–23.
- Hulsken J, Birchmeier W, Behrens J. E-cadherin and APC compete for the interaction with fi-catenin and the cytoskeleton. J Cell Biol 1994; 127: 2061–9.